CTRI/2023/03/050307已完成4 期
A clinical observational study to evaluate Safety and Efficacy of HSTF-022206 in Healthy Adult Subjects in reduction of facial dark spots.
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Age: 18 to 55 years (both inclusive) at the time of consent.
- •2. Sex: Healthy non-pregnant/non-lactating females and Males.
- •3. Subject has facial dark spots includes sun-tan, blemishes,
- •sunspots, and age spots.
- •4. Female of childbearing potential must have a reported negative
- •pregnancy during screening.
- •5. Subject is generally in good health.
- •6. Subject has not undergone any cosmetic procedures or any
- •medication for the treatment of acne or facial dark spots 3
- •months prior to study enrolment and willing to forgo any
- •treatment duration of the study
排除标准
- •1.Subject has a history of allergy or sensitivity to the test treatment ingredients
- •2.Subject who has a history of allergy with products containing
- •turmeric or any known ingredients.
- •3. Subject who has pre-existing or dormant dermatologic
- •conditions (e.g., psoriasis rashes, eczema, seborrheic dermatitis,
- •acne, acne rosacea or any other) that could interfere with the
- •subject selection and outcome of the study as determined by
- •the Investigator.
研究者
相似试验
招募中
不适用
An observational study to evaluate the safety and efficacy of MegaDerm Soft in patients who underwent breast reconstruction using the MegaDerm soft.KCT0007432Soon Chun Hyang University Hospital Bucheon60
招募中
4 期
An observational study to evaluate the safety and efficacy of FOLFIRI / FOLFOX plus Cetuximab as first-line therapy inpatients with KRAS wild-type metastatic Colorectal cancerCTRI/2010/091/000161Merck Specialities Pvt Limited5th Floor , Shivsagar EstateDr. Annie Besant RoadMumbai 400018100
尚未招募
Unknown
An observational study to evaluate the safety and efficacy of lenvatinib plus pembrolizumab combination therapy for advanced or recurrent uterine cancer after use of platinum-based drugs(GOGO-EM4)JPRN-UMIN000049997Gynecologic Oncology Group of Osaka(GOGO)100
尚未招募
4 期
Versius Clinical StudyCTRI/2022/08/045073CMR Surgical India Pvt Ltd
尚未招募
2 期
Versius Clinical Study in Robot Assisted Total HysterectomyCTRI/2022/09/045789CMR Surgical India Pvt Ltd